Assessing the Effect of Patient Characteristics on Treatment Response in Primary Hyperhidrosis

Completed

Conditions studied: Hyperhidrosis

In brief

This study will describe the treatment of hyperhidrosis (excessive sweating) in clinical practice and explore the effect of patient characteristics on treatment response. This study will follow 200 people with hyperhidrosis over 18 months. Anyone with primary hyperhidrosis (excessive sweating not due to another medical condition) over the age of 12 may participate. Study participants will have multiple office visits during which they will asked to rate the severity of their sweat production in multiple areas (i.e. underarms, hands, feet), answer a questionnaire regarding their disease and treatment, and undergo a non-invasive measurement of sweat production called gravimetry. Gravimetry is performed by placing absorbent material in an area, such as the underarms, for a set amount of time and then measuring the amount of sweat collected. In between clinic visits, study participants will be contacted electronically to answer several questions regarding their disease and treatment.

Key facts

Study ID

NCT03694093

Run by

St. Louis University

People needed

41

Starts

2018-08-20

Expected to finish

2019-12-01

Last updated by the study team

2020-02-05

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female of any race who has received the diagnosis of primary Hyperhidrosis at any site
• Patients receiving continued treatment of primary Hyperhidrosis with baseline gravimetrics (established patients only) performed at SLUCare Dermatology Des Peres clinic. Baseline gravimetrics are defined as measurements taken during times of no active disease interventions.

You may not qualify if…

• Received the following therapies at the site being evaluated prior to baseline gravimetrics:
• Botulinum toxin injections 6 months prior to baseline gravimetric data collection.
• Applied Aluminum chloride on day of baseline gravimetric data
• Ongoing iontophoresis therapy at time of baseline gravimetric data
• Oral systemic anticholinergics 4 weeks prior to baseline gravimetric data
• Received surgical intervention, suction and curettage, microwave thermolysis, or ultrasound therapy prior to baseline gravimetrics.
• Patient has received diagnosis of secondary hyperhidrosis (i.e hyperhidrosis due to an underlying medical condition such as hyperthyroidism)
• Younger than 12 years of age.
• Does not desire study participation or is unable to consent.

Where it is running

• Saint Louis University — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.